0001562180-17-003379.txt : 20171030
0001562180-17-003379.hdr.sgml : 20171030
20171030165625
ACCESSION NUMBER: 0001562180-17-003379
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171030
FILED AS OF DATE: 20171030
DATE AS OF CHANGE: 20171030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eansor Norman David
CENTRAL INDEX KEY: 0001270905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 171163021
MAIL ADDRESS:
STREET 1: 8100 SOUTHPARK WAY, A-8
CITY: LITTLETON
STATE: CO
ZIP: 80120
FORMER NAME:
FORMER CONFORMED NAME: EANSOR N DAVID
DATE OF NAME CHANGE: 20031120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-10-30
false
0000842023
BIO-TECHNE Corp
TECH
0001270905
Eansor Norman David
8100 SOUTHPARK WAY, A-8
LITTLETON
CO
80120
false
true
false
false
SVP - Novus Biologicals
Common Stock
3402.00
D
Restricted Stock Units
2017-10-26
4
A
false
2174.00
0.00
A
Common Stock
2174.00
2174.00
D
Stock Options (Right to buy)
125.05
2017-10-26
4
A
false
11982.00
0.00
A
2024-08-09
Common Stock
11982.00
11982.00
D
Stock Options (Right to buy)
125.05
2017-10-26
4
A
false
15976.00
0.00
A
2024-08-09
Common Stock
15976.00
15976.00
D
Restricted Stock Units
Common Stock
1500.00
1500.00
D
Restricted Stock Units
Common Stock
2287.00
2287.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
12500.00
12500.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
9375.00
9375.00
D
Stock Option (Right to Buy)
94.35
2021-08-12
Common Stock
15000.00
15000.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
18819.00
18819.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
14114.00
14114.00
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Vest 3,994 shares on each 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.
/s/ Brenda S. Furlow, attorney in fact for David N. Eansor pursuant to Power of Attorney filed here with
2017-10-30
EX-24
2
eansorpoa2017.txt
EANSORPOA2017
POWER OF ATTORNEY
The undersigned hereby constitutes and
appoints Brenda S. Furlow, James Hippel, Anna
Weispfenning, Melodie R. Rose, Andrew Nick,
Sarah Tucher or either of them acting alone,
the undersigned's true and lawful attorneys-
in-fact and agent with full power of
substitution and resubstitution, for the
undersigned and in the undersigned's name,
place and stead, in any and all capacities,
to sign any or all Forms 3, Forms 4 and
Forms 5 relating to beneficial ownership of
securities of Bio-Techne Corporation (the
"Issuer"), to file the same, with all
exhibits thereto and other documents in
connection therewith, with the Securities and
Exchange Commission and to deliver a copy of
the same to the Issuer, granting unto said
attorney-in-fact and agent full power and
authority to do and perform each and every
act and thing requisite and necessary to be
done in and about the premises, as fully to
all intents and purposes as the undersigned
might or could do in person, hereby ratifying
and confirming all said attorneys-in-fact and
agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue
thereof. The undersigned acknowledges that
the foregoing attorney-in-fact, in serving in
such capacity at the request of the
undersigned, is not assuming any of the
undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of
1934.
This Power of Attorney shall remain in
effect until such time as the undersigned is
no longer subject to the provisions of
Section 16 of the Securities Exchange Act of
1934 with respect to securities of the
Issuer.
IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be executed
as of this 3rd day of October, 2017.
/s/ N. David Eansor